Bihua Han

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Bihua Han, Yufei Song, Changgui Li et al. · The Lancet Infectious Diseases · 2021 · 355 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +16

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

Gang Zeng, Qianhui Wu, Hongxing Pan et al. · The Lancet Infectious Diseases · 2021 · 287 citations · Full text

Veterinary Medicine, Immunology, Immunization +13

A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Minjie Li, Juan Yang, Lin Wang et al. · medRxiv · 2021 · 37 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination

Yuliang Zhao, Bihua Han, Xinjiang Zhang et al. · BMC Infectious Diseases · 2019 · 34 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials

Qianqian Xin, Qianhui Wu, Xinhua Chen et al. · Nature Communications · 2022 · 24 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17